2021

1. High versus standard doses of corticosteroids in severe COVID-19: a retrospective cohort study

   European Journal of Clinical Microbiology and Infectious Diseases, Vol. 40, Núm. 4, pp. 761-769

2. Non-severe immunosuppression might be associated with a lower risk of moderate–severe acute respiratory distress syndrome in COVID-19: A pilot study

   Journal of Medical Virology, Vol. 93, Núm. 4, pp. 2243-2251

3. The Impact of Immunosuppression and Autoimmune Disease on Severe Outcomes in Patients Hospitalized with COVID-19

   Journal of Clinical Immunology, Vol. 41, Núm. 2, pp. 315-323